PMID: 9663920Jul 15, 1998Paper

What is the plasma cofactor required by diuretics for direct vascular relaxant effect in vitro?

Journal of Hypertension
Z AbrahamsJ M Wright

Abstract

To determine the plasma cofactor which is required by diuretics (hydrochlorothiazide, chlorthalidone, indapamide, and furosemide) for direct vasorelaxant effects in vitro. A randomized, double-blind, vehicle-control design was used to avoid experimenter bias. We plotted concentration-response curves for responses to hydrochlorothiazide, chlorthalidone, indapamide, and furosemide of male Wistar rat aortic rings in the presence of different bath solutions containing various plasma factors. Plasma was found both to make possible and facilitate the vasodilator action of the diuretics tested by an action on the membrane and to decrease the action by binding the diuretics. The diuretics retained their vasorelaxant properties in Krebs solution alone, 30 min after having been incubated in a 50:50 solution of Krebs solution and plasma for 1 h. All four diuretics exerted significant vasorelaxant actions in Krebs solution-plasma, Krebs solution-serum, and Krebs solution plus human or bovine albumin (40 g/l) media. No vasorelaxant action was found in Krebs solution alone, Krebs solution plus denatured plasma, Krebs solution plus egg albumin, and Krebs solution plus insulin. Albumin is the main cofactor required by the diuretics tested for ...Continue Reading

References

Dec 2, 1977·European Journal of Clinical Pharmacology·B Beermann, M Groschinsky-Grind
Jan 1, 1975·Current Medical Research and Opinion·S WitchitzP Chiche
Jan 1, 1975·Current Medical Research and Opinion·P Y Hatt, J B Leblond
Jul 1, 1975·Clinical Pharmacology and Therapeutics·D S AdlerJ P Spire
Jan 1, 1992·Journal of Cardiovascular Pharmacology·T Grser, G M Rubanyi
Sep 10, 1992·European Journal of Pharmacology·J A CalderP S Sever
Oct 1, 1989·Canadian Journal of Physiology and Pharmacology·G Pillai, M C Sutter
Feb 1, 1989·Journal of Pharmacokinetics and Biopharmaceutics·M Hammarlund-Udenaes, L Z Benet
Nov 1, 1988·Pharmacology & Toxicology·F Andreasen, J H Christensen
Jun 1, 1987·Pflügers Archiv : European journal of physiology·F P GerstheimerV A Kreye
Jul 1, 1973·Toxicology and Applied Pharmacology·D S Campion
Jan 1, 1973·Acta Pharmacologica Et Toxicologica·F Andreasen
Jan 1, 1971·Acta Pharmacologica Et Toxicologica·A H Anton, W T Corey
Jul 1, 1983·American Heart Journal·J H Morledge
Mar 1, 1980·Clinical Pharmacology and Therapeutics·P van BrummelenM A Schalekamp
May 1, 1980·Clinical Pharmacokinetics·B Beermann, M Groschinsky-Grind
Jul 17, 1981·European Journal of Pharmacology·V A KreyeI Villhauer
Oct 1, 1994·American Heart Journal·S S Franklin, M A Weber

❮ Previous
Next ❯

Citations

Nov 9, 2000·European Journal of Pharmacology·B ColasM Andrejak
Jul 27, 2001·Fundamental & Clinical Pharmacology·L GalánJ L Alvarez
Apr 2, 2005·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Alun D Hughes
Jun 10, 2010·Expert Review of Cardiovascular Therapy·Julio D Duarte, Rhonda M Cooper-DeHoff
Nov 25, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Robert M RapoportManoocher Soleimani
Sep 24, 2019·Frontiers in Pharmacology·Robert M Rapoport, Manoocher Soleimani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.